Targeting oncogenic Myc as a strategy for cancer treatment

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The MYC oncogene is frequently deregulated in human cancers, correlating with poor prognosis.
• MYC plays a critical role in regulating cell proliferation, apoptosis, differentiation, and metabolism.
• Directly inhibiting MYC is challenging due to its 'undruggable' protein structure.

Purpose of the Study:

• To review recent advancements in targeting oncogenic MYC for cancer therapy.
• To explore alternative strategies for MYC inhibition beyond direct blockade.

Main Methods:

• Literature review of studies on MYC targeting strategies.
• Analysis of approaches including Myc/Max complex disruption, MYC transcription/translation inhibition, MYC destabilization, and synthetic lethality.

Main Results:

• Several alternative strategies show promise in achieving anti-tumor effects.
• These include targeting MYC interactions, expression, and dependencies.

Conclusions:

• Targeting MYC remains a critical goal in cancer therapy.
• Emerging strategies offer viable alternatives to direct MYC inhibition, advancing cancer treatment possibilities.